Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan vs Dobutamine in Cardiorenal Syndrome
NCT02133105Phase 3Completed
- Sponsor
- University of Gothenburg
- Start
- Apr 2014
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levosimendan in cardiorenal syndrome (CRS), sponsored by University of Gothenburg. Started Apr 2014; status: completed.
02
Drugs
levosimendan
03
Conditions
cardiorenal syndrome (CRS)
Beyond the preview
Go deeper on NCT02133105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02133105.